Glutamine and tight glycemic control: Chicken or egg?

Critical Care Medicine

Volumn 36, Issue 6, 2008, Pages 1965-1966

  Griffiths, Richard D ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Euglycemia; Glucose; Glutamine; Insulin; Nutrition; Tight glycemic control

Indexed keywords

GLUTAMINE; INSULIN; MUSCLE PROTEIN;

CANCER PATIENT; CLINICAL PROTOCOL; EDITORIAL; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; INSULIN TREATMENT; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RISK FACTOR; SAFETY; SEPSIS; THERAPY EFFECT; TOTAL PARENTERAL NUTRITION; ABDOMINAL TUMOR; BLOOD; CROSSOVER PROCEDURE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN RESISTANCE; INTENSIVE CARE; METABOLISM; METHODOLOGY; NOTE; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL;

ABDOMINAL NEOPLASMS; BLOOD GLUCOSE; CROSS-OVER STUDIES; GLUTAMINE; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; INTENSIVE CARE; MUSCLE PROTEINS; PARENTERAL NUTRITION, TOTAL; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 45149130874     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181761672     Document Type: Editorial

References (14)

1. Bongers T, Griffiths RD, McArdle A: Exogenous glutamine: The clinical evidence. Crit Care Med 2007; 35(Suppl 9):S545-S552
2. Meyer C, Woerle HJ, Gerich J: Paradoxical changes of glutamine release during hyperin-sulinemia euglycemia and hypoglycaemia in humans: Further evidence for glucose- glutamine cycle. Metabolism 2004; 53: 1208-1214
3. Biolo G, De Cicco M, Lorenzon S, et al: Treating hyperglycaemic improves skeletal muscle protein metabolism in cancer patients after major surgery. Crit Care Med 2008; 36:1768-1775
4. Biolo G, Iscra F, Bosutti A, et al: Growth hormone decreases muscle glutamine production and stimulates protein synthesis in hypercatabolic patients. Am J Physiol Endocrinol Metab 2000; 279:E323-E332
5. Brunkhost FM, Engel C, Bloos F, et al: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Medt 2008; 358:125-139
6. Van den Berghe G, Wilmer A, Milants I, et al: Intensive insulin therapy in mixed medical/ surgical intensive care unit: Benefits versus harm. Diabetes 2006; 55:3151-3159
7. Carlson G: Hunterian Lecture: Insulin resistance in human sepsis: Implications for the nutritional and metabolic care of the critically ill surgical patient. Ann R Coll Surg Engl 2004; 86:75-81
8. Van den Berghe G, Wilmer A, Hermans G, et al: Intensive insulin therapy in the medical ICU. N Engl J Medt 2006; 354:449-461
9. Borel MJ, Williams PE, Jabbour K, et al: Parenteral glutamine infusion alters insulin-mediated glucose metabolism. JPEN J Par-enter Enteral Nutr 1998; 22:280-285
10. Iwashita S, Mikus C, Baier S, et al: Glutamine supplementation increases postprandial energy expenditure and fat oxidation in humans. JPEN J Parenter Enteral Nutr 2006; 30:76-80
11. Déchelotte P, Hasselmann M, Cynober L, et al: L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: The French controlled, randomized, double-blind, multicenter study. Crit Care Med 2006; 34:598-604
12. Bakalar B, Duska F, Pachl J, et al: Parenter-ally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple-trauma patients. Crit Care Med 2006; 34:381-386
13. Griffiths RD: Too much of a good thing: The curse of overfeeding. Crit Care 2007; 11:176
14. Dissanaike S, Shelton M, Warner K, et al: The risk for bloodstream infections is associated with increased parenteral caloric intake in patients receiving parenteral nutrition. Crit Care 2007; 11:R114